Don't miss this PILMA video highlight of Assemblyman Anthony Verrelli (Asm. Anthony Verrelli) for #NationalApprenticeshipWeek!

This is a wild stat for PCMA to be bragging about on their insulin site.

There is no evidence to suggest that IP protections are limiting access to Covid-19 diagnostics and therapeutics, but waiving them will harm the #biopharma industry's ability to recoup investment and hamper future R & D. phrma.org/resource-cente…

The Inflation Reduction Act will inhibit the development of generic & biosimilar medications and treatments that lower patient costs and generate savings for the broader healthcare system, putting the most vulnerable patient groups at risk.

House Democrats urge Tai to weigh ‘adverse’ effects of broadening TRIPS waiver | InsideTrade.com insidetrade.com/daily-news/hou…

Antimicrobial Resistance (AMR) occurs when bacteria, viruses, fungi and parasites change over time and no longer respond to medicines. Learn more about the risks and what can be done by watching this short video: youtube.com/watch?v=3CfAD4…

Happy Thanksgiving from your friends at We Work for Health New Jersey!

AMR is especially concerning for patients with chronic diseases like Cystic Fibrosis (CF). Here is a heartbreaking account from a CF patient's mother about how AMR caused her daughter's death -- and what can be done to prevent more tragedies like hers. usatoday.com/story/opinion/…

The PASTEUR Act would create a more sustainable environment for antimicrobial R&D and ensure a robust pipeline for future treatments. A national group of 150+ organizations recently signed a letter encouraging Congress to pass it. Read the letter here: cff.org/sites/default/…

This recent PhRMA blog post explains how expanding TRIPS waiver to include Covid-19 therapies would inhibit biopharmaceutical research and development. Read it here: catalyst.phrma.org/expanding-trip…

Brian May, Executive Director of Oregon State Pharmacy Association, was a guest on the Rob Taylor Report for a discussion about the organization's report on how #PBMs impact community pharmacies. Listen here: robtaylorreport.com/the-rob-blog/t…

Don't miss this op-ed by former U.S. Representative Joe Crowley on the dangers posed to patients by the proposed WTO TRIPS waiver. Read the piece here: northjersey.com/story/opinion/… via NorthJersey.com

Biden administration must protect U.S. biotech firms from foreign rivals chicago.suntimes.com/2022/11/19/234…

“Share the Savings” legislation would prohibit #PBMs from pocketing prescription drug discounts meant for patients and help lower out-of-pocket costs for prescription drugs.theinteriorjournal.com/2022/11/15/its…

In an op-ed supporting a bill that would create a reverse #PBM auction for the state, CO State Senators Dominick Moreno and Janice Rich note that New Jersey has already saved $2.5 billion in prescription drug costs since the passage of similar legislation. coloradopolitics.com/opinion/if-don…

Drug-resistant pathogens claim lives and add billions to healthcare costs. Read more about how #AMR impacts the State of New Jersey in this infographic from The Partnership to Fight Infectious Disease (PFID): files.constantcontact.com/9e73e151901/53…

Former FTC policy director David Balto outlines the ways questionable #PBM practices harm the most vulnerable patients in this InsideSources article. dcjournal.com/vulnerable-pat…

We must create a more sustainable environment for antimicrobial R&D and commercialization, and ensure a robust pipeline for future treatments. #AMR #PassThePASTEURAct

This KEZI 9 NEWS segment highlights the Oregon State Pharmacy Association report that showed how #PBMs tactics are driving independent pharmacies out of business. kezi.com/news/new-repor…

Happy holidays from your friends at We Work for Health New Jersey and best wishes for a healthy New Year!